Guangzhou Baiyunshan Proposes Governance Amendments and Supervisory Committee Dissolution

An update from Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ) is now available.

Guangzhou Baiyunshan Pharmaceutical Holdings Company has announced proposed amendments to its Articles of Association, Rules of Procedures for Shareholders’ Meetings, and Rules of Procedures for the Board of Directors, alongside the dissolution of its Supervisory Committee. These changes are in response to the new Company Law and aim to enhance corporate governance and operational standardization. The statutory functions of the Supervisory Committee will now be handled by the Audit Committee, subject to shareholder approval at the upcoming general meeting.

The most recent analyst rating on (HK:0874) stock is a Hold with a HK$21.70 price target. To see the full list of analyst forecasts on Guangzhou Baiyunshan Pharmaceutical Holdings Company stock, see the HK:0874 Stock Forecast page.

More about Guangzhou Baiyunshan Pharmaceutical Holdings Company

Guangzhou Baiyunshan Pharmaceutical Holdings Company is a pharmaceutical company based in China, primarily engaged in the production and distribution of pharmaceutical products. The company operates within the healthcare industry and focuses on providing a wide range of pharmaceutical solutions.

Average Trading Volume: 1,599,749

Technical Sentiment Signal: Buy

Current Market Cap: HK$45B

Learn more about 0874 stock on TipRanks’ Stock Analysis page.